Tissue-specific and paradoxical bile acid–FXR/TGR5 signaling in MASLD: reframing the brain–gut–liver axis
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized as a multisystem disorder in which hepatic metabolic injury coexists with intestinal dysbiosis and neurobehavioral abnormalities. Bile acids function not only as digestive molecules but also as inter-organ signals through the nuclear receptor farnesoid X receptor (FXR) and the membrane receptor Takeda G protein-coupled receptor 5 (TGR5). This review reframes the bile acid–FXR/TGR5 pathway from a brain–gut–liver perspective, with particular emphasis on tissue-specific and sometimes paradoxical receptor functions. We summarize hepatic, intestinal, and central FXR/TGR5 signaling; discuss humoral and vagal routes linking the gut–liver axis with the brain; and critically examine conflicting findings arising from model selection, sex, bile acid profiling strategies, and global vs. tissue-specific receptor manipulation. We further reinterpret current therapeutic approaches, including FXR agonists, TGR5 agonists, GLP-1 receptor agonists, and natural products, in terms of tissue selectivity and central exposure. The available evidence supports a shift from indiscriminate receptor activation toward compartment-selective modulation, while also highlighting the need for prospective human studies, multi-tissue omics, and direct assessment of central bile acid signaling.
Authors
- Junhong Liu
- Yajing Li (ORCID: https://orcid.org/0009-0008-4976-0541)
Institutions
- Gansu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fmed.2026.1990233
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gansu University of Chinese Medicine